A single day of 1% O2 conditioning of HER2-CAR-T cells significantly enhanced their immunotherapeutic function against SKOV3 tumours, as shown by significantly decreased tumour growth rates, and by increased animal survival, relative to animals receiving 21% O2-treated CAR-T cells (Figure 6G and H). Here, ERBB2 is linked to neoplasm.